1-2 of 2
Pierpaolo Fattori
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.

Pier Luigi Zinzani, MD, PhD, Alessandro Pulsoni, MD, Manuela Balocco, MD, Monica Tani, MD, Stefano Fanti, MD, Alessio Perrotti, MD, Paolo Castellucci, MD, Francesco Zaja, MD, Alberto Fabbri, MD, Alfonso Zaccaria, MD, Maria Teresa Voso, MD, Pierpaolo Fattori, MD, Luciano Guardigni, MD, Patrizia Gentilini, MD, Maria Giuseppina Cabras, MD, Amalia De Renzo, MD, Luigi Rigacci, MD
Journal: Blood
Blood (2006) 108 (11): 2479.
https://doi.org/10.1182/blood.V108.11.2479.2479
Published: 2006
Journal Articles

Idiopathic Hypereosinophilic Syndrome (HES) with FIP1L1-PDGFRA Rearrangement Can Be Effectively Treated with Imatinib.

Giovanni Martinelli, Daniela Cilloni, Emanuela Ottaviani, Michele Malagola, Francesca Messa, Michela Rondoni, Costanza Bosi, Enrico Gottardi, Gianantonio Rosti, Paolo Ricci, Stavroula Gaitani, Fabrizio Pane, Nicoletta Testoni, Cristina Mecucci, Simona Soverini, Pier Paolo Piccaluga, Marilina Amabile, Mario Tiribelli, Alfonso Zaccaria, Tiziana Grafone, Antonello De Vivo, Stefano Pileri, Pierpaolo Fattori, Monica Bocchia, Anna Serra, Luca Maurillo, Renato Fanin, Nicholas C.P. Cross, Serena Merante, Mario Cazzola, Giuliana Alimena, Francesco Frassoni, Piero Galieni, Domenico Russo, Marco Gobbi, Luigi Gugliotta, Francesco Lauria, Patrizio Mazza, Felicetto Ferrara, Filippo Gherlinzoni, Pietro Leoni, Pellegrino Musto, Michele Baccarani, Giuseppe Saglio
Journal: Blood
Blood (2004) 104 (11): 1504.
https://doi.org/10.1182/blood.V104.11.1504.1504
Published: 2004